Amesite Inc (AMST) concluded trading on Thursday at a closing price of $2.50, with 43.85 million shares of worth about $109.63 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 8.23% during that period and on February 27, 2025 the price saw a gain of about 4.60%. Currently the company’s common shares owned by public are about 3.99M shares, out of which, 3.14M shares are available for trading.
Stock saw a price change of 0.81% in past 5 days and over the past one month there was a price change of -27.75%. Year-to-date (YTD), AMST shares are showing a performance of -47.37% which increased to 16.01% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.85 but also hit the highest price of $6.27 during that period. The average intraday trading volume for Amesite Inc shares is 104.40K. The stock is currently trading -17.94% below its 20-day simple moving average (SMA20), while that difference is down -29.30% for SMA50 and it goes to -15.84% lower than SMA200.
Amesite Inc (NASDAQ: AMST) currently have 3.99M outstanding shares and institutions hold larger chunk of about 4.31% of that.
The stock has a current market capitalization of $9.99M and its 3Y-monthly beta is at 1.02. It has posted earnings per share of -$1.76 in the same period. It has Quick Ratio of 1.63 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for AMST, volatility over the week remained 25.85% while standing at 12.44% over the month.
Analysts are in expectations that Amesite Inc (AMST) stock would likely to be making an EPS of 0 in the current quarter, while forecast for next quarter EPS is 0 and it is 0 for next year. For the current quarter EPS, analysts have given the company a lowest target 0 which is 0 at the higher side of the target for the same.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by The Benchmark Company on December 28, 2020 offering a Speculative buy rating for the stock and assigned a target price of $7 to it.
